China Pioneer Pharma Holdings Ltd
1345Shanghai Pioneer Holding Ltd, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People's Republic of China. The company offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas. It also sells medical devices, including ophthalmology, orthopedics, odontology, and wound care products. In addition, the company engages in sale of ancillary tools, dental devices, and imported in-licensed prescription products, as well as accessories leasing; research and development of denture and implants dentistry; Medical research and experimental development; and provision of metal finishing services. It sells its products to hospitals and medical institutions, and pharmacies. The company was formerly known as China Pioneer Pharma Holdings Limited. Shanghai Pioneer Holding Ltd was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pioneer Holding Ltd is a subsidiary of Pioneer Pharma (BVI) Co., Ltd. Address: No.15, Lane 88 Wuwei Road, Shanghai, China, 200331
Analytics
主に工業および宝飾用の金属です。市場が不況を予想し、生産が低下すると、価値は下がります。宝飾品業界からの需要も不安定です。現在、プラチナは金よりも安く、それで作られたアイテムはエリートと見なされません。
26.40 HKD生産が消費をまかなえない場合、供給不足の脅威があります。物理的な金属の不足への恐れの中で、価格は上昇します。しかし、これが不況の予想とともに起こると、価格にはほとんど影響がありません。これは2008年と2023年に明確に見られました。
16.79配当利回り
3.07 %今年
去年
今四半期
前四半期
今年
去年
今四半期
前四半期
主要人物 1345
配当分析 1345
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–